Search Browse Earnings

Pharma-Bio Serv, Inc.

OTC:PBSV

Services-Management Consulting Services·DORADO, PR

Overview All Filings Sum Fin Credit Insiders Governance

Overview All Filings Sum Fin Credit Insiders Governance

Summary Financials

Pharma-Bio Serv, Inc. — SlamSEC

Revenue

$9.5M

-44.0% YoY

FY 2025

Adj. EBITDA

-$1.2M

-12.8% margin

FY 2025

Net Income

-$777,619

-8.2% margin

FY 2025

EPS (Diluted)

-$0.03

FY 2025

Stock Price

—

52W Range

—

P/E Ratio

—

Market Cap

—

Cash

$17.5M

FY 2022

Total Debt

—

Net Cash

$17.5M

FY 2025

Enterprise Value

—

Debt / EBITDA

14.4x

FY 2025

EV / EBITDA

—

Employees

—